SouthViews No. 205, 31 August 2020
Digital Sequence Information (DSI) and national measures: approaches and perspectives
By Jorge Cabrera Medaglia
Digital sequence information (DSI, or genetic sequence data) is an emerging aspect of synthetic biology which involves certain functional genetic sequences being shared by different means. The genetic sequences from plants, animals or micro-organisms could be used to support conservation and sustainable use of biological diversity, to develop and commercialize new products and processes, or for other purposes. The regulation of the use of DSI for both commercial and non-commercial entities may have huge implications for the access and benefit-sharing (ABS) regimen established in the international instruments, ongoing processes and regional and national legislation that implement these conventions. International guidance is needed to promote a coordinated approach to secure fair and equitable sharing of benefits while avoiding a negative impact on the non-commercial benefits arising from the genetic data.
Download the SouthViews:
Digital Sequence Information (DSI) and national measures: approaches and perspectives
This article was tagged: Access and Benefit-Sharing (ABS), Biological Diversity, Convention on Biological Diversity (CBD), Costa Rica, Digital Sequence Information (DSI), Food and Agriculture Organization (FAO), Genetic Resources, Genetic Sequence Data (GSD), International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA), Mutually Agreed Terms (MAT), Nagoya Protocol, Prior Informed Consent (PIC), World Health Organization (WHO)
